对阿片类药物滥用威配方的审查:影响和进入障碍
1Dr. Vince Clinical Research, Overland Park, KS, USA.
Journal of pain research
|June 10, 2024
概括
滥用威剂 (ADF) 的目的是减少阿片类药物的滥用和转移. 虽然一些ADF显示出希望,但与非ADF阿片类药物相比,需要进一步研究它们的有效性和成本.
科学领域:
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
- 药物输送系统 药物输送系统
背景情况:
- 阿片类止痛药对慢性疼痛至关重要,但存在滥用,滥用和转移的重大风险.
- 延长释放 (ER) 类阿片类配方虽然有效,但容易被操纵以滥用.
- 滥用威剂 (ADFs) 是为了通过阻碍操纵和非口服的使用来减轻这些风险而开发的.
研究的目的:
- 审查延长释放 (ER) 类阿片类药物滥用威制剂 (ADF) 的开发和有效性.
- 为了比较不同ADF技术的滥用威特性,例如DETERx和RESISTEC.
- 突出ADF利用的挑战,包括患者获取和进一步实践有效性和成本研究的需要.
主要方法:
- 对ER阿片类配方和ADF的现有文献的审查.
- 分析评估特定ADF技术的有效性和滥用威性能的研究.
- 检查市场后关于ADF利用和结果的真实世界数据.
主要成果:
- 与非ADF配方相比,ADF已经证明了阿片类药物滥用和转移率的降低.
- 像DETERx (Xtampza ER) 这样的特定技术即使在被操纵时也保持延长释放特性,与其他一些ADF不同.
- 患者获取问题,如高成本和缺乏保险覆盖,阻碍了ADF的广泛采用.
结论:
- 在减少阿片类药物滥用,滥用和转移方面,ADFs代表了重大进展.
- 进一步的现实研究是必不可少的,以比较各种ADF的与滥用有关的有效性和医疗保健成本.
- 对ADF的好处和操纵潜力的加强临床医生教育对于它们的最佳利用至关重要.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
276
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
276
Analgesia and Pain Management
579
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
579
Prescription, Nonprescription and Orphan Drugs
720
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
720
Opioid Receptors: Overview
729
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
729
Opioid Analgesics: Morphine and Other Natural Cogeners
234
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
234
Drug Control Governance: Regulatory Bodies and Their Impact
153
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
153


